Category - Developments

Developments

KA Imaging to present lateral dual-energy X-ray views at ECR 2021

Closely-held KA Imaging will present a poster on results from a study examining the feasibility of lateral chest dual-energy subtraction radiography using a stacked single-exposure multi-layer x-ray detector at the...

February 24, 2021

Developments

IntelGenx receives U.S. patent allowance for DisinteQ disintegrating THC oral film

The U.S. Patent and Trademark Office granted a notice of allowance for an IntelGenx (TSXV:IGX; OTCQB:IGXT) patent application entitled, “Film Dosage Form with Extended Release Mucoadhesive Particles.” This film...

February 17, 2021

Developments

HEXO to acquire Zenabis Global

HEXO (TSX, NYSE:HEXO) agreed to acquire Zenabis Global (TSX:ZENA) by way of a court-approved plan of arrangement under the Business Corporations Act of British Columbia, in an all-share transaction valued at...

February 16, 2021

Developments

Notch Therapeutics in $85-million financing for stem cell cancer immunotherapies

Closely-held Notch Therapeutics closed an $85-million series A financing to support continuing development of its portfolio of induced pluripotent stem cell (iPSC)-derived T-cell therapeutic product candidates and...

February 10, 2021

Developments

Richardson Wealth, Bloom Burton in healthcare alliance to expand wealth solutions

Richardson Wealth, a unit of RF Capital Group (TSX:RCG), and Bloom Burton, two Canadian financial services firms, entered into a strategic alliance dedicated exclusively on the healthcare sector. The strategic alliance...

February 9, 2021

Developments

MD Anderson completes second cohort dosing in Phase 1b trial of Soricimed’s SOR-C13

MD Anderson Cancer Center has completed patient dosing in the second cohort of a Phase 1b investigator-initiated trial of Soricimed Biopharma’s lead drug candidate, SOR-C13, for the targeted treatment of solid tumor...

February 8, 2021

Developments

IntelGenx files provisional U.S. patent for VetaFilm high loading oral film platform

IntelGenx (TSXV:IGX; OTCQB:IGXT) filed a new provisional patent application with the U.S. Patent and Trademark Office entitled, “High Loading Oral Film Formulation.” The patent application covers the incorporation of...

February 8, 2021

Developments

111 Inc. in pact with Jilin Baiyi Doctor Group for internet medical services

111 Inc. (NASDAQ:YI) and Jilin Baiyi Doctor Group Management entered into a strategic partnership to leverage the capabilities of 111’s digital platform to provide SMART-enabled healthcare services and doctor...

February 5, 2021

Developments

FDA clears Soliton RAP technology for cellulite improvement

The FDA cleared Soliton’s (NASDAQ:SOLY) Rapid Acoustic Pulse (RAP) technology for the short-term improvement in the appearance of cellulite. Soliton’s rapid-pulsed technology safely and comfortably breaks apart the...

February 1, 2021

Developments

Titan Pharma posts positive early study results for JT-09 ProNeura program

Titan Pharmaceuticals (NASDAQ:TTNP) announced that studies of its kappa opioid agonist peptide, JT-09, has demonstrated high potency and specificity for the human kappa-opioid receptor (KOR). JT-09 is being developed...

February 1, 2021

Category - Developments

KA Imaging to present lateral dual-energy X-ray views at ECR 2021

IntelGenx receives U.S. patent allowance for DisinteQ disintegrating THC oral film

HEXO to acquire Zenabis Global

Notch Therapeutics in $85-million financing for stem cell cancer immunotherapies

Richardson Wealth, Bloom Burton in healthcare alliance to expand wealth solutions

MD Anderson completes second cohort dosing in Phase 1b trial of Soricimed’s SOR-C13

IntelGenx files provisional U.S. patent for VetaFilm high loading oral film platform

111 Inc. in pact with Jilin Baiyi Doctor Group for internet medical services

FDA clears Soliton RAP technology for cellulite improvement

Titan Pharma posts positive early study results for JT-09 ProNeura program

General

More